I thought SR articulated the story very well. as SR mentioned it's taken the market a while to digest it. Liking the references to Ivanhoe backing the project and the interest coming internationally. Syerston, with CLQ's tech being in the lowest quartile cost of production is also something that the market is slowly beginning to understand.
SR is right, once people (broker incl) digest what's going on here with the base cases of 300-400m cash flow pa in the PFS then the 700m US is not capital intensive. This is a 40 yr resource after all.
A few obviously joined the dots today...
- Forums
- ASX - By Stock
- in the news
I thought SR articulated the story very well. as SR mentioned...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRL (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.0¢ |
Change
0.005(1.75%) |
Mkt cap ! $25.71M |
Open | High | Low | Value | Volume |
30.0¢ | 31.0¢ | 28.5¢ | $28.24K | 94.86K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12456 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 1652 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12456 | 0.285 |
1 | 2535 | 0.280 |
1 | 1500 | 0.270 |
1 | 2500 | 0.265 |
1 | 2000 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 1652 | 1 |
0.295 | 3568 | 2 |
0.300 | 15555 | 1 |
0.305 | 10447 | 2 |
0.310 | 6289 | 2 |
Last trade - 12.34pm 12/11/2024 (20 minute delay) ? |
Featured News
SRL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online